Advertisement
Persons > France
Please find below persons from France.Total search results: 1294 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Genne, Philippe (Oncodesign 201209 CEO + Founder) | Chief Executive Officer (CEO) | Oncodesign S.A. (Alternext: ALONC) | Bourgogne-Franche-Comté (Burgundy-Free County) (region) |
Gerard, Pierre-Emmanuel (Biomunex 2014– CEO + Co-Founder) | Chief Executive Officer (CEO) | Biomunex Pharmaceuticals SASU | Île-de-France (region) |
Germain, Pierre-Louis (Ulysee Communication 202306) | Public Relations Manager / Investor Relations Manager | Ulysse Communication GIE | Île-de-France (region) |
Gervat, Vincent (Sanofi 201407 RnD France) | Research & Development Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
Giabicani, Gabriel (France (govt) 202112 Director Operation + Innovation at Investment Dept of Banque des Territoires) | n. a. | France (govt) | France (region/state unspecified) |
Gidoin, Thomas (GenSight Biologics 201507 CFO) | Chief Financial Officer (CFO) | GenSight Biologics S.A. (Euronext: SIGHT) | Île-de-France (region) |
Gilly, Bernard (GenSight Biologics 201304 CEO + Co-founder before Fovea + Sofinnova Partners + Transgene) | Chief Executive Officer (CEO) | GenSight Biologics S.A. (Euronext: SIGHT) | Île-de-France (region) |
Girard, Wilfrid (Medeuronet 201705 CEO + Founder) | Chief Executive Officer (CEO) | Medeuronet SAS | Grand Est (Great East) (region) |
Giraut, Claire (Mérieux 201309– designated future CFO of bioMérieux before Ipsen + Europcar) | Chief Financial Officer (CFO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
Glaser, Patrick (Novasep 201210–201306 CEO before Head Novasep Synthesis division since 5/10 LEFT 6/13) | Chief Executive Officer (CEO) | Novasep (Group) | Grand Est (Great East) (region) |
Glezer, Stan (Adocia 201804 CMO) | Chief Medical Officer (CMO) | Adocia S.A. | Auvergne-Rhône-Alpes (region) |
Glocer, Thomas H. (Tom) (Thomson-Reuters 200804 CEO) | Chief Executive Officer (CEO) | Thomson (Group) | France (region/state unspecified) |
Goarant, Cédric (13advisory 201509 Managing Partner) | Managing Partner (investment firm) | 13advisory (FR) | Auvergne-Rhône-Alpes (region) |
Godard, Augustin (INSERM 201509 Open Innovation Manager at Inserm Transfert) | Business Development Manager / Strategy Manager | France (govt) | Île-de-France (region) |
Godet, Vanessa (France (govt) 201509 Media Relations Manager at bpifrance) | Public Relations Manager / Investor Relations Manager | France (govt) | Île-de-France (region) |
Goffart, Lucien (Robocath 202004 CEO) | Chief Executive Officer (CEO) | Robocath SAS | Normandie (Normandy) (region) |
Gohaud, Romain (Theravectys 201310 CFO) | Chief Financial Officer (CFO) | Theravectys S.A. | Île-de-France (region) |
Goineau, Pierre-Olivier (Erytech Pharma 201412 CEO + Co-founder + Chair of France Biotech) | Chief Executive Officer (CEO) | Erytech (Group) | Auvergne-Rhône-Alpes (region) |
Golaz, Louis (RED Horticulture 202311 CEO + Co-Founder) | Chief Executive Officer (CEO) | RED Horticulture (Rouge Engineered Designs) (Group) | Auvergne-Rhône-Alpes (region) |
Gonthiez, Thierry (Resolution Spectra Systems 202007 General Manager + Co-Founder) | General Manager (management) | Merck (DE) (Group) | Auvergne-Rhône-Alpes (region) |
Gonzalez Aseguinolaza, Gloria (Vivet Therapeutics 201705 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vívet Therapeutics (Group) | Île-de-France (region) |
Gonzalez, Céline (Andrew Loyd and Associates 2013) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | Île-de-France (region) |
Goupit, Philippe (MedDay 201501– Non-executive Board Director before Sanofi VP Corporate Licenses) | Board member, non-executive | MedDay Pharmaceuticals SAS | Île-de-France (region) |
Gouze, Elvire (InnoSkel 202012 CEO + Founder + INSERM + before TherAchon) | Chief Executive Officer (CEO) | InnoSkel SAS | Provence-Alpes-Côte d’Azur (region) |
Grangeon, Jean Medhi (ATCG Partners 201507) | Public Relations Manager / Investor Relations Manager | ATCG Partners (FR) | Provence-Alpes-Côte d’Azur (region) |
Granier, Luc-André (Advicenne 201712 CEO + Co-Founder) | Chief Executive Officer (CEO) | Advicenne S.A. (Euronext Paris: ADVIC) | Occitanie (Occitania) (region) |
Gréciet, Judith (BioAlliance Pharma 201306 CEO + France Biotech 201508 Board Member) | Chief Executive Officer (CEO) | Onxeo (Group) | Île-de-France (region) |
Greenwood, Luba (Kojin Therapeutics 202110– CEO before Cathay Health + Binney Street Capital + Pfizer + Google + Roche) | Managing Partner (investment firm) | Kojin Therapeutics Inc. | Massachusetts (federal state) |
Grienenberger, Aurélie (Eligo Bioscience 201909– CBO before Sanofi Global Business Development) | Chief Business Officer (CBO) | Eligo Bioscience S.A. | Île-de-France (region) |
Grimaud, Franck (Vivalis 200702 CEO) | Chief Executive Officer (CEO) | Valneva (Group) | Pays de la Loire (region) |
Grofik, George (Sanofi 201801 Investor Relations) | Public Relations Manager / Investor Relations Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
Grognet, Jean-Marc (Genopole 201709 CEO) | Chief Executive Officer (CEO) | Genopole (GIP Genopole) | Île-de-France (region) |
Gros, Marie-Françoise (Mérieux 201806 Medical Director at bioMérieux) | Chief Medical Officer (CMO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
Grossmann, Benoist (Eurazeo 201306 Managing Partner at Idinvest Partners) | Managing Partner (investment firm) | Eurazeo (Group) | Île-de-France (region) |
Grow, Matthew (Stilla Technologies 202106– VP Global Marketing + Commercial Operations before Abcam + WuXi NextCODE) | Sales Manager / Marketing Manager | Stilla Technologies (Group) | Île-de-France (region) |
Groyer, Sébastien (BPCE 201507 Parter at Seventure Partners) | Partner (venture partner) | BPCE (Group) | Île-de-France (region) |
Grupp, Stephan A. (Children’s Hospital Philadelphia 201809 + 201809– Cellectis Clinical Advisory Board Member) | Researcher (university / research institute) | Children’s Hospital of Philadelphia (CHOP) | Pennsylvania (federal state) |
Guedat, Philippe (Hybrigenics 200606 Head of Chemistry) | n. a. | Hybrigenics (Group) | Île-de-France (region) |
Guedj, Jean-Yves (Sanesco 201005 President) | President/Director/Head Business Group/Unit/Division | General Electric (Group) | |
Guenoun, Alexandre (Kiro 202303 CEO + Founder) | Chief Executive Officer (CEO) | Kiro (FR) (Group) | Provence-Alpes-Côte d’Azur (region) |
Guerbert, Stephane (bioMerieux 200401 CE Marketing project manager) | Sales Manager / Marketing Manager | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
Guerci, Laurent (Abionyx 202307– Chief Digital + Innovation Officer before ACTIA + PWC) | Chief Information Officer (CIO) / Chief Digital Officer | Abionyx (Group) | Occitanie (Occitania) (region) |
Guérin, Lionel (ScienceOne 202306 CEO) | Chief Executive Officer (CEO) | ScienceOne SAS | Île-de-France (region) |
Guez, David (Servier 201706 Head of WeHealth by Servier) | President/Director/Head Business Group/Unit/Division | Servier (Group) | France (region/state unspecified) |
Guichard, Christophe (Netris Pharma 202211 CFO + Eclosion2 202211 General Partner + CFO) | Chief Financial Officer (CFO) | Netris Pharma SAS | Auvergne-Rhône-Alpes (region) |
Guillaumot, Vincent (ArchiMed 2014 Partner + Co-Founder before JS Bio) | Partner (venture partner) | ArchiMed (Group) | Auvergne-Rhône-Alpes (region) |
Guillen, Christine (ElsaLys 201305– COO + Co-founder before Transgene) | Chief Operating Officer (COO) | Mediolanum (Group) | Auvergne-Rhône-Alpes (region) |
Guillot, Thomas (OSE Immunotherapeutics 202210 Invesor Relations) | Public Relations Manager / Investor Relations Manager | OSE Immunotherapeutics (Group) | Pays de la Loire (region) |
Guinot, Philippe (Crédit Agricole Private Equity 200603 Board Member PanGenetics 200603–) | n. a. | Coller Capital (Group) | Île-de-France (region) |
Guiral, Myriam (SeqOne 202201 CCO) | Chief Commercial Officer (CCO) | SeqOne SAS (SeqOne Genomics) | Occitanie (Occitania) (region) |
Guitard, Olivier (Sartorius 202111 Managing Director Sartorius Stedim FMT + Head Controlling Bioprocess Solutions Div) | Managing Director | Sartorius (Group) | Provence-Alpes-Côte d’Azur (region) |
Gut, Ivo (Centre National de Génotypage 200401 Project Coordinator) | n. a. | Centre National de Génotypage (CNG) | Île-de-France (region) |
Guyon-Gellin, Delphine (Osivax 202007 Chief Business Development Officer) | Business Development Manager / Strategy Manager | Osivax (Group) | Auvergne-Rhône-Alpes (region) |
Guyon-Gellin, Nicolas (Enyo Pharma 201805– VP Corp Development + Strategy before Morgan Stanley + Exane BNP + Amundi) | Business Development Manager / Strategy Manager | Enyo Pharma S.A. | Auvergne-Rhône-Alpes (region) |
Hadida, Benjamin (NextBiotix 201807 CEO + Co-Founder) | Chief Executive Officer (CEO) | Exeliom Biosciences SAS | Bourgogne-Franche-Comté (Burgundy-Free County) (region) |
Halfon, Philippe (Genoscience Pharma 201712 CEO) | Chief Executive Officer (CEO) | Genoscience Pharma SAS | Provence-Alpes-Côte d’Azur (region) |
Hamilton, Gordon (Depixus 202112 CEO + Co-Founder) | Chief Executive Officer (CEO) | Depixus (Group) | Île-de-France (region) |
Hamon, Gwenaël (Kreaxi 201703 Investment Director) | Investment Manager | Kreaxi (FR) | Île-de-France (region) |
Hamoumi, Zina (CorWave 2018–2023 CFO LEFT 03/23 before Victoria Beckham + Lundbeck France + Mexx + PwC) | Chief Financial Officer (CFO) | CorWave S.A. | Île-de-France (region) |
Hardy, Anne (ComCopr 201506 ) | Public Relations Manager / Investor Relations Manager | ComCorp SAS | Île-de-France (region) |
Harnest, Simon (Metagenomi 202107– Chief Investment Officer + SVP Strategy before Cellectis + Trout Group) | Public Relations Manager / Investor Relations Manager | Metagenomi Inc. | California (federal state) |
Harosh, Itzik (ObeTherapy 200001– CEO + Founder) | Chief Executive Officer (CEO) | ObeTherapy Biotechnology (FR) | Île-de-France (region) |
Harrington, Michael C. (Mike) (Waters 201601– SVP Global Markets before VP European + Asia Pacific Operations) | Regional manager | Waters (Group) | Île-de-France (region) |
Hart, Celia (CEA 202312 General Partner at Supernova Invest before CEA Investissement) | Investment Manager | CEA (Group) | Île-de-France (region) |
Hascoët, Gérard (CorWave 201611 Board Chairman) | Board member, non-executive | CorWave S.A. | Île-de-France (region) |
Hawken, John B. (Immutep 201310 CEO) | Chief Executive Officer (CEO) | Immutep (Group) | Île-de-France (region) |
Heckmann, Dieter (Daicel Chemical 201006 President Chiral Technologies Europe) | President/Director/Head Business Group/Unit/Division | Daicel (Group) | Grand Est (Great East) (region) |
Hédou, Julien (SurgeCare 202403 CEO + Co-Founder) | Chief Executive Officer (CEO) | SurgeCare SAS | Grand Est (Great East) (region) |
Heilbronn, Laurence (Image Sept 201405 Partner + Consultant) | Public Relations Manager / Investor Relations Manager | Image Sept (FR) | Île-de-France (region) |
Hennebel, Thomas (Dionymer 202206 CEO + Co-Founder) | Chief Executive Officer (CEO) | Dionymer (FR) | Nouvelle-Acquitaine (New Acquitaine) (region) |
Hennion, Claude (Oncodiag 202211 CEO) | Chief Executive Officer (CEO) | OncoDiag (FR) | France (region/state unspecified) |
Henrie, Hunt (Tissium 2021020– CBO before Locust Walk + Ferghana Partners + JP Morgan Chase) | Chief Business Officer (CBO) | Tissium (Group) | Île-de-France (region) |
Henrotte, Maud (France (govt) 202211 Investment Director at Bpifrance) | Investment Manager | France (govt) | Île-de-France (region) |
Hercend, Thierry (Andera Partners 201902 Venture Partner) | Partner (venture partner) | Andera Partners (FR) | Île-de-France (region) |
Hess, Philipp (Laboratoire Phycotoxines 201309) | Researcher (university / research institute) | Laboratoire Phycotoxines, Infremer | Pays de la Loire (region) |
Heuzé, David (MedinCell 202005 Corporate Communications) | Public Relations Manager / Investor Relations Manager | MedinCell (Group) | Occitanie (Occitania) (region) |
Hiance, Maryvonne (France Biotech 201902 CHairman + Effimune 201310 President) | Cluster Manager | France Biotech | Île-de-France (region) |
Higueret, Laurent (France (govt) 201509 at Bpifrance Large Venture) | Investment Manager | France (govt) | Île-de-France (region) |
Hilbrich, Lutz (Minapharm 202006– CEO of ProBioGen AG before Sanofi China + Boehringer Ingelheim) | Chief Executive Officer (CEO) | Minapharm (Group) | Berlin (federal state) |
Hoang-Sayag, Loan (Andera Partners 202206 Venture Partner formerly Cellectis 201706–201710 CMO LEFT 10/17) | Venture Partner | Andera Partners (FR) | Île-de-France (region) |
Hoffmann, Caroline (Oxygen 202206) | Public Relations Manager / Investor Relations Manager | Oxygen SAS (RP, Agence Conseil en Communication Media) | Île-de-France (region) |
Hoflack, Jan (Oncodesign 201311 CSO + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Oncodesign S.A. (Alternext: ALONC) | Bourgogne-Franche-Comté (Burgundy-Free County) (region) |
Hofmann, Francesco (Pierre Fabre 202110 at Pierre Fabre Medical Care) | n. a. | Pierre Fabre (Group) | Île-de-France (region) |
Holder, Jean-Marc (SeqOne 202201 Chief Strategy + Innovation Officer + Co-Founder) | Business Development Manager / Strategy Manager | SeqOne SAS (SeqOne Genomics) | Occitanie (Occitania) (region) |
Hong, Kinam (Sofinnova 202204 Partner at Sofinnova Partners) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
Horvais, Alain (Kurma Partners 201506 Partner at Kurma Diagnostics) | Partner (venture partner) | Eurazeo (Group) | Île-de-France (region) |
Houette, Arnaud (Extens Développement e-Santé 201712 Managing Director) | Managing Director | Extens Développement e-Santé | Île-de-France (region) |
Hu, Hongjie (Cathay Capital 202108 Managing Partner + Co-Founder of Cathay Health) | Managing Partner | Cathay Capital (Group) | New York (federal state) |
Hubert, Antoine (Ynsect 2011– President + Co-founder) | President/Director/Head Business Group/Unit/Division | Ynsect SAS | Île-de-France (region) |
Hue, Baudouin (Karista 202206 Partner) | Partner (venture partner) | Karista (FR) | France (region/state unspecified) |
Huerre, Maxime (Eurazeo 202403 VP Venture) | President/Director/Head Business Group/Unit/Division | Eurazeo (Group) | Île-de-France (region) |
Huguet, Stéphane (Mutabilis 202001 CEO) | Chief Executive Officer (CEO) | Pharma Omnium (Group) | Île-de-France (region) |
Hultén, Corrie (SK Group 202202– Executive Director Business Development before Porton Advanced + Patheon) | Business Development Manager / Strategy Manager | SK Group (Group) | Île-de-France (region) |
Hum, Dean (Genfit 201909 COO + CSO) | Chief Operating Officer (COO) | Genfit (Group) | Hauts-de-France (Upper France) (region) |
Humbey, Olivier (Accovion 201412– Country Director France) | Regional manager | Clinipace (Group) | Auvergne-Rhône-Alpes (region) |
Huneker, Erik (Diabeloop 201912 Co-CEO + Founder) | Chief Executive Officer (CEO) | Diabeloop S.A. | Auvergne-Rhône-Alpes (region) |
Huot, Valéry (LBO France 201709 Head of Innovation Capital) | Investment Manager | LBO France | France (region/state unspecified) |
Huriez, Alain (Advent France Biotechnology 201704 Managing Partner before Advent Life Sciences + TcLand + Neovacs) | Managing Partner (investment firm) | AdBio Partners (Group) | Île-de-France (region) |
Huynh, Emmanuel (NewCap 201404) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
Hyllner, Johan (Cellectis 201111– CSO of Cellectis Stem Cells before Cellartis 201109 CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Cellectis (Group) | Île-de-France (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top